Systematix Corp invests Rs 10 Cr in wholly-owned subsidiary SWASPL

Business Updates View source PDF Explain this filing

SYSTMTXC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Reaction day

₹75.46

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.3%+0.3% vs market

Stockbroking & Allied peers, median of 39sector-0.1%+0.1% vs sector

On the reaction day the stock moved 0.3 pts more than Nifty Microcap 250 and 0.1 pts more than its Stockbroking & Allied peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.0-0.3+0.3-0.1+0.1

Next day

-2.0-1.5-0.4-0.3-1.7

-2.6-1.5-1.1+0.5-3.1

-3.2-0.2-2.9+2.2-5.3

-5.1-0.5-4.6+1.2-6.3

-3.3-3.2-0.0-0.1-3.1

-1.3-2.2+0.8+0.5-1.8

15d

+1.4-9.5+10.9-5.3+6.7

—————

UpDownMarket · Nifty Microcap 250Sector · Stockbroking & Allied peers, median of 39Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Systematix Corporate Services has invested Rs 10 crore in its wholly-owned subsidiary Systematix Wealth and Asset Services Private Limited (SWASPL) by subscribing to 1 crore equity shares of Rs 10 each at par through a rights issue. SWASPL operates in alternative investment funds, wealth management, and financial product distribution. Its FY26 turnover was Rs 193.06 lakhs, up from nil in FY25. The funds will be used for SWASPL working capital needs. The deal is a cash transaction at arm's length, and there is no change in shareholding as SWASPL remains a wholly-owned subsidiary.

Likely market impact

Routine capital infusion into wholly-owned subsidiary to support working capital. No ownership change. Largely neutral for shareholders.